Learning objectives
After watching this webinar, participants will know how to assess and manage CV risk in diabetes.
Needs assessment and expected educational outcome
Publication of a new clinical guideline on Cardiovascular Disease and Diabetes – This webinar will address evidence behind the main changes in the Cardiovascular Disease and Diabetes Guidelines about the risk factor management and to understand how the changes impact clinical practice.
See "more details" for subsequent webinar topics.
This programme is supported by Novo Nordisk in the form of an unrestricted financial support. The scientific programme has not been influenced in any way by its sponsor.
Main topic:
This webinar is part of the "ESC 2023 Clinical Practice Guidelines – Webinar Series on Cardiovascular Disease and Diabetes".
For more focused information about this topic, please watch the following webinars:
For a complete overview of the Cardiovascular Disease and Diabetes topic please visit the Focus webpage.
Discover the complete ESC Education offer on the 2023 Guidelines here.
Session information
This webinar is designed for general practitioners, primary care doctors and general cardiologist but also cardiologists wishing to update their scientific knowledge on the topic.
During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
Technical settings
The webinar is available on PC and tablets. The use of a smartphone is not recommended.
To answer the MCQs during the live, you must allow pop-up windows.
A high-speed Internet connection is required (minimum 2 Mbps).